| Classifica | Nome della clinica | Valutazione dei pazienti | Paese | Medico principale | esperienza | Tecniche | Migliore per | Perché è in classifica | Accreditamenti |
|---|---|---|---|---|---|---|---|---|---|
| #1 | 4.7 / 5 (440 recensioni) | Barcelona, Spain | 37+ anni23,000+ trattamenti | Ocrelizumab (Ocrevus), Natalizumab (Tysabri), Rituximab, immunomodulatory therapy | MS patients needing evidence-based treatments | Offers specialized immunotherapies including Ocrevus, led by neurologist Dr. Anna Pujol with 36 years of experience. Clinic provides individualized therapy protocols and psychological support. | Joint Commission International , European Foundation for Quality Management | ||
| #2 | 4.5 / 5 (0 recensioni) | Madrid, Spain | — | — | — | — | — | Joint Commission International , International Organization for Standardization | |
| #3 | 4.1 / 5 (3 recensioni) | Alicante, Spain | 16+ anni | — | — | — | Joint Commission International | ||
| #4 | 4.5 / 5 (0 recensioni) | Marbella, Spain | 53+ anni | Multiple sclerosis rehabilitation, Consultation with a recreation therapist | — | — | ISO 9001:2015 Quality management systems | ||
| #5 | 3.8 / 5 (6 recensioni) | Madrid, Spain | 30+ anni | Ocrevus (ocrelizumab), medication treatment for multiple sclerosis | Advanced multiple sclerosis cases | Offers Ocrevus treatment for multiple sclerosis. Doctors have conducted over 100 clinical trials in neuroscience. Neurology department led by an expert with 4,500+ citations. | World's Best Hospitals 2021 by Newsweek | ||
| #6 | 4.4 / 5 (6 recensioni) | Barcelona, Spain | 44+ anni | — | — | — | Joint Commission International | ||
| #7 | 4.8 / 5 (41 recensioni) | Barcelona, Spain | — | 14,000+ trattamenti | Consultation with a neurologist | — | — | Bookimed Award: Best pediatric hospital, World's Best Specialized Hospitals 2022 by Newsweek | |
| #8 | 3.4 / 5 (0 recensioni) | Madrid, Spain | — | — | — | — | — | Joint Commission International | |
| #9 | 4.6 / 5 (16 recensioni) | Madrid, Spain | — | 26,000+ trattamenti | Ocrevus (ocrelizumab) | Patients requiring advanced MS treatments | Offers Ocrevus therapy for Multiple sclerosis. Part of a large neuroscience center with access to clinical trials and English-speaking support. | European Foundation for Quality Management, TÜV AG Сompany Research & Investing Certificate | |
| #10 | 2.5 / 5 (0 recensioni) | Madrid, Spain | 27+ anni | — | — | — | European Foundation for Quality Management, Certification according to DIN EN ISO 9001 by TÜV NORD CERT |